Covid-19 roundup: Moderna, US sign contract for autumn booster doses; Enanta touts PhI results for its antiviral

The US government has placed a contract for 66 million doses of Moderna’s Covid-19 vaccine booster candidate, and the deal could balloon to another 234 million doses.

The contract includes up to $1.74 billion for Moderna to manufacture and deliver the doses of the bivalent vaccine candidate, dubbed mRNA-1273.222. The shot contains antigens against the BA.4/BA.5 Omicron subvariant strains and is part of Moderna’s effort to deliver a booster shot this autumn, pending the necessary go-ahead from the FDA and CDC.

Per shot, that’s $26.36. In August 2020, the US bought 100 million doses of the Moderna vaccine for about $10 less, at approximately $15.75 a pop, according to Reuters. Meanwhile, the European Union has in the past paid between $22.60 to $25.50 for each Moderna dose, according to the New York Times.

“We look forward to receiving these new variant-specific vaccines…
Click here to view original post